317 related articles for article (PubMed ID: 34193368)
1. Relationship Between Genitourinary Syndrome of Menopause and 3D High-Frequency Endovaginal Ultrasound Measurement of Vaginal Wall Thickness.
Peker H; Gursoy A
J Sex Med; 2021 Jul; 18(7):1230-1235. PubMed ID: 34193368
[TBL] [Abstract][Full Text] [Related]
2. Dyspareunia Related to GSM: Association of Total Vaginal Thickness via Transabdominal Ultrasound.
Balica AC; Cooper AM; McKevitt MK; Schertz K; Wald-Spielman D; Egan S; Bachmann GA
J Sex Med; 2019 Dec; 16(12):2038-2042. PubMed ID: 31542351
[TBL] [Abstract][Full Text] [Related]
3. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
[TBL] [Abstract][Full Text] [Related]
4. Assessing vaginal wall thickness by transvaginal ultrasound in breast cancer survivors: A pilot study.
Ros C; Mension E; Rius M; Munmany M; De Guirior C; Espuña-Pons M; Anglès-Acedo S; Castelo-Branco C
Maturitas; 2023 May; 171():7-12. PubMed ID: 36863187
[TBL] [Abstract][Full Text] [Related]
5. Association Between Pelvic Floor Muscle Strength and Sexual Function in Postmenopausal Women.
Omodei MS; Marques Gomes Delmanto LR; Carvalho-Pessoa E; Schmitt EB; Nahas GP; Petri Nahas EA
J Sex Med; 2019 Dec; 16(12):1938-1946. PubMed ID: 31680007
[TBL] [Abstract][Full Text] [Related]
6. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
7. A Novel Method for the Measurement of the Vaginal Wall Thickness by Transvaginal Ultrasound: A Study of Inter- and Intra-Observer Reliability.
Bosio S; Barba M; Vigna A; Cola A; De Vicari D; Costa C; Volontè S; Frigerio M
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541095
[No Abstract] [Full Text] [Related]
8. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
9. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study.
Pinheiro C; Costa T; Amorim de Jesus R; Campos R; Brim R; Teles A; Vilas Boas A; Lordêlo P
BMC Womens Health; 2021 Oct; 21(1):379. PubMed ID: 34717608
[TBL] [Abstract][Full Text] [Related]
10. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study.
Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto C;
Climacteric; 2018 Apr; 21(2):167-173. PubMed ID: 29411644
[TBL] [Abstract][Full Text] [Related]
11. Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study.
Zhu Y; Wei J; Yang X; Zhu W; Zhang W
BMC Womens Health; 2022 Dec; 22(1):558. PubMed ID: 36585649
[TBL] [Abstract][Full Text] [Related]
12. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
13. Assessing the thickness of the vaginal wall and vaginal mucosa in pre-menopausal versus post-menopausal women by transabdominal ultrasound: A feasibility study.
Balica A; Wald-Spielman D; Schertz K; Egan S; Bachmann G
Maturitas; 2017 Aug; 102():69-72. PubMed ID: 28610687
[TBL] [Abstract][Full Text] [Related]
14. Measurement of the vaginal wall thickness by transabdominal and transvaginal ultrasound of women with vaginal laxity: a cross-sectional study.
Pereira GMV; Juliato CRT; de Almeida CM; Valente IS; de Andrade KC; Brito LGO
Int Urogynecol J; 2022 Dec; 33(12):3563-3572. PubMed ID: 35384478
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause.
Okui N; Okui M; Kouno Y; Nakano K; Gambacciani M
Cureus; 2023 May; 15(5):e38604. PubMed ID: 37284382
[TBL] [Abstract][Full Text] [Related]
16. Does the vaginal wall become thinner as prolapse grade increases?
Bray R; Derpapas A; Fernando R; Khullar V; Panayi DC
Int Urogynecol J; 2017 Mar; 28(3):397-402. PubMed ID: 27678142
[TBL] [Abstract][Full Text] [Related]
17. Relationships between the vaginal microbiota and genitourinary syndrome of menopause symptoms in postmenopausal women: the Study of Women's Health Across the Nation.
Waetjen LE; Crawford SL; Gajer P; Brooks MM; Gold EB; Reed BD; Hess R; Ravel J
Menopause; 2023 Nov; 30(11):1073-1084. PubMed ID: 37788422
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
19. Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review.
Moccia F; Pentangelo P; Ceccaroni A; Raffone A; Losco L; Alfano C
Aesthetic Plast Surg; 2023 Dec; 47(6):2788-2799. PubMed ID: 37580562
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
